Intra-bone marrow-bone marrow transplantation (IBM-BMT) with perfusion method - Intra-bone marrow-bone marrow transplantation (IBM-BMT)

Kansai Medical University0 sites5 target enrollmentDecember 3, 2010

ConditionsRefractory hematological malignancies (acute leukemia, chronic myeloid leukemia, myelodysplastic syndrome, malignant lymphoma)

Overview

Phase: Phase 1
Intervention: Not specified
Conditions: Refractory hematological malignancies (acute leukemia, chronic myeloid leukemia, myelodysplastic syndrome, malignant lymphoma)
Sponsor: Kansai Medical University
Enrollment: 5
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

December 3, 2010

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Kansai Medical University

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Positivity of HBs Ag, HIV Ab (not exclusion of HCV Ab positive) Patient with active infection Bone marrow show fibrosis Patients who are considered as inappropriate with other reasons

Outcomes

Primary Outcomes

Not specified

Similar Trials

Suspended

Phase 1

Intra-bone marrow-bone marrow transplantation (IBM-BMT) with perfusion methodRefractory hematological malignancies (acute leukemia, chronic myeloid leukemia, myelodysplastic syndrome, malignant lymphoma)

JPRN-UMIN000003555Kansai Medical University5

Recruiting

Phase 1

Allogeneic Intrabone marrow transplantation using bone marrow cells obtained by usual aspiration method: phase I/II studychronic myeloid leukemia, acute myeloid leukemia, acute lymphoid leukemia, myelodysplastic syndrome malignant lymphoma

JPRN-UMIN000007654Hyogo College of Medicine26

Completed

Phase 2

Intra-bone marrow injection of cord blood following reduced-intensity conditioning: A phase II studyRefractory hematologic malignancies (acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome, malignant lymphoma)

JPRN-UMIN000006529Hyogo College of Medicine30

Completed

Not Applicable

Bone marrow mononuclear cell implantation for patients with critical limb ischemiaPeripheral Arterial Disease (PAD) , Buerger disease, and arteritis associated with collagen diseases (Fontaines stage: III and IV)

JPRN-UMIN000021422BMI Study Group

Active, not recruiting

Phase 1

Administration of bone marrow adult autologous mesenchymal cells expanded in chronically establish low injuries of the spinal cord

EUCTR2017-000975-10-ESFundación Investigación Biomédica Hospital Universitario Puerta de Hierro Majadahonda15